Double trouble: IRAK1/4 inhibitors in AML/MDS

Blood. 2023 Sep 14;142(11):945-946. doi: 10.1182/blood.2023020812.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Humans
  • Interleukin-1 Receptor-Associated Kinases
  • Leukemia, Myeloid, Acute* / drug therapy
  • Myeloid Differentiation Factor 88
  • Neoplasms, Second Primary*
  • Signal Transduction

Substances

  • Myeloid Differentiation Factor 88
  • Adaptor Proteins, Signal Transducing
  • IRAK1 protein, human
  • Interleukin-1 Receptor-Associated Kinases